IL10 and cancer: On the contrary, cancer cells induce the dysfunction of effector T cells through upregulation of inhibitory molecules (e.g., PD-L1 and CTLA-4) or synthesis of immunosuppressive cytokines (e.g., TGF-β, IL-1, IL-6, and IL-10) (138).